Cangene Corporation (CC:CNJ) Acquires Twinstrand Therapeutics
7/8/2009 6:48:20 AM
More...
|
Phase I Data for Twinstrand Therapeutics Drug TST10088 to Be Presented at International Cancer Therapeutics Conference
10/1/2007 12:29:39 PM
More...
|
Twinstrand Therapeutics Files IND Application For Immunogen in Ricin Antidote Study
9/25/2007 11:37:50 AM
More...
|
Twinstrand Therapeutics Announces Award Of $2.2 M CDN Research Contract By The US Department Of Defense For Development Of A Medical Countermeasure To Ricin
9/12/2006 2:37:33 PM
More...
|
Twinstrand Therapeutics Announces It Has Initiated A Phase I Clinical Trial For TST10088
10/19/2005 5:09:43 PM
More...
|
Twinstrand Therapeutics Announces US FDA Approval Of Its IND Application For Clinical Development Of TST10088
10/19/2005 5:09:02 PM
More...
|